Authorized commercial representation. Direct manufacturer contracts.

U.S. Business Development Partner for EU Nutraceutical Manufacturers

We help U.S. brands evaluate innovative technologies and formulations, receive documentation under NDA, and launch private label or licensing projects.
All contracts and payments are executed directly between the client and the manufacturer.
AvalenPharm manages the process to reduce risk and timelines.

Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration



Who we are

AvalenPharm is a U.S.-based business development company supporting U.S. nutraceutical brands in sourcing and evaluating EU manufacturing partners with differentiated technologies and formulations.
We act as an authorized commercial representative, facilitating NDA-based evaluation and commercial alignment. All contracts and payments are executed directly between the client and the manufacturer.

Start a Confidential Discussion
Share your portfolio focus, and we will outline relevant EU manufacturing opportunities under NDA.

01


What we do

We support U.S. brands in:
Identifying relevant EU manufacturers based on portfolio strategy and market focus

Receiving technical documentation under NDA

Aligning commercial parameters such as MOQ, timelines, and supply formats

Advancing projects efficiently toward direct manufacturer engagement

Pharmacutical consulting AvalenPharm
Pharmacutical consulting AvalenPharm

02


How we work

Our approach is structured and transparent:
1. Portfolio fit assessment
2. NDA-based documentation review
3. Commercial and operational alignment with the manufacturer
4. Direct contract execution between the client and the manufacturer
5. Ongoing coordination through launch readiness

02


How we work

Our approach is structured and transparent:

1. Portfolio fit assessment

2. NDA-based documentation review

3. Commercial and operational alignment with the manufacturer

4. Direct contract execution between the client and the manufacturer

5. Ongoing coordination through launch readiness

Pharmacutical consulting AvalenPharm

03


TRANSPARENT, NDA-BASED BUSINESS DEVELOPMENT MODEL

Our business model is built on transparency and risk reduction.
• NDA-based evaluation• Direct contracts and payments executed with manufacturers• No intermediaries in the supply chain• One U.S.-based point of contact throughout the process
This structure allows U.S. companies to explore EU manufacturing opportunities with confidence, clarity, and control.

Pharmacutical consulting AvalenPharm

Our partners

Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration
Illustration

Start a Confidential DiscussionShare your portfolio focus, and we will outline relevant EU manufacturing opportunities under NDA.

Contact us

Thank you!

We will contact you shortly

Can't send form.

Please try again later.